Ident. | Authors (with country if any) | Title |
---|
000040 (2017) |
C. Kendell ; K. M. Decker [Canada] ; P. A. Groome ; M. L. Mcbride ; L. Jiang ; M. K. Krzyzanowska ; G. Porter ; D. Turner [Canada] ; R. Urquhart ; M. Winget [États-Unis] ; E. Grunfeld [Canada] | Use of physician services during the survivorship phase: a multi-province study of women diagnosed with breast cancer |
000303 (2017) |
Lu Yang [République populaire de Chine] ; Juan Cheng [République populaire de Chine] ; Yuli Chen [République populaire de Chine] ; Shengjie Yu [République populaire de Chine] ; Fengqiu Liu [République populaire de Chine] ; Yang Sun [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Haitao Ran [République populaire de Chine] | Phase-Transition Nanodroplets for Real-Time Photoacoustic/Ultrasound Dual-Modality Imaging and Photothermal Therapy of Sentinel Lymph Node in Breast Cancer |
000304 (2017) |
Xue Qin Yu [Australie] ; Qingwei Luo [Australie] ; David P. Smith [Australie] ; Mark S. Clements [Suède] ; Manish I. Patel [Australie] ; Dianne L. O Onnell [Australie] | Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study |
000471 (2017) |
S. Mestre [France] ; C. Calais ; G. Gaillard ; M. Nou ; M. Pasqualini [France] ; C. Ben Amor [France] ; I. Quere [France] | Interest of an auto-adjustable nighttime compression sleeve (MOBIDERM® Autofit) in maintenance phase of upper limb lymphedema: the MARILYN pilot RCT |
000789 (2017) |
Chai Hong Rim [Corée du Sud] ; Sung-Ja Ahn ; Jin Hee Kim [Corée du Sud] ; Won Sup Yoon ; Mison Chun ; Dae Sik Yang [Corée du Sud] ; Jong-Hoon Lee [Corée du Sud] ; Kyubo Kim [Corée du Sud] ; Moonkyoo Kong [Corée du Sud] ; Suzy Kim [Corée du Sud] ; Juree Kim [Corée du Sud] ; Kyung Ran Park [Corée du Sud] ; Young-Joo Shin [Corée du Sud] ; Sun Young Ma [Corée du Sud] ; Bae-Kwon Jeong ; Su Ssan Kim [Corée du Sud] ; Yong Bae Kim [Corée du Sud] ; Dong Soo Lee ; Jaehyung Cha | An assessment of quality of life for early phase after adjuvant radiotherapy in breast cancer survivors: a Korean multicenter survey (KROG 14–09) |
000801 (2017) |
Valérie Fonteyne [Belgique] ; Piet Dirix [Belgique] ; Sara Junius [Belgique] ; Elke Rammant [Belgique] ; Piet Ost [Belgique] ; Gert De Meerleer [Belgique] ; Martijn Swimberghe [Belgique] ; Karel Decaestecker [Belgique] | Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial |
000811 (2017) |
David Cameron [Royaume-Uni] ; James P. Morden [Royaume-Uni] ; Peter Canney [Royaume-Uni] ; Galina Velikova [Royaume-Uni] ; Robert Coleman [Royaume-Uni] ; John Bartlett [Canada] ; Rajiv Agrawal [Royaume-Uni] ; Jane Banerji [Royaume-Uni] ; Gianfilippo Bertelli [Royaume-Uni] ; David Bloomfield [Royaume-Uni] ; A Murray Brunt [Royaume-Uni] ; Helena Earl [Royaume-Uni] ; Paul Ellis [Royaume-Uni] ; Claire Gaunt [Royaume-Uni] ; Alexa Gillman [Royaume-Uni] ; Nicholas Hearfield [Royaume-Uni] ; Robert Laing [Royaume-Uni] ; Nicholas Murray [Royaume-Uni] ; Niki Couper [Royaume-Uni] ; Robert C. Stein [Royaume-Uni] ; Mark Verrill [Royaume-Uni] ; Andrew Wardley [Royaume-Uni] ; Peter Barrett-Lee [Royaume-Uni] ; Judith M. Bliss [Royaume-Uni] | Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial |
000A91 (2016) |
Amy E. Cyr [États-Unis] ; Natalia Tucker [États-Unis] ; Foluso Ademuyiwa [États-Unis] ; Julie A. Margenthaler [États-Unis] ; Rebecca L. Aft [États-Unis] ; Timothy J. Eberlein [États-Unis] ; Catherine M. Appleton [États-Unis] ; Imran Zoberi [États-Unis] ; Maria A. Thomas [États-Unis] ; Feng Gao [États-Unis] ; William E. Gillanders [États-Unis] | Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound |
000B14 (2016) |
Marcin Szyma Ski ; Daria Młynarek ; Arkadiusz Szyma Ski ; Irena Matławska | Simultaneous Determination of Diosmin and Hesperidin in Pharmaceuticals by RPLC using Ionic Liquids as Mobile Phase Modifiers |
000E94 (2016) |
Michelle Glasgow [États-Unis] ; Rachel Isaksson Vogel [États-Unis] ; Jennifer Burgart [États-Unis] ; Peter Argenta [États-Unis] ; Kathryn Dusenbery [États-Unis] ; Melissa A. Geller [États-Unis] | Long term follow-up of a phase II trial of multimodal therapy given in a “sandwich” method for stage III, IV, and recurrent endometrial cancer |
001276 (2016) |
Jens Jakob [Allemagne] ; Anna Simeonova [Allemagne] ; Bernd Kasper [Allemagne] ; Ulrich Ronellenfitsch [Allemagne] ; Geraldine Rauch [Allemagne] ; Frederik Wenz [Allemagne] ; Peter Hohenberger [Allemagne] | Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03) |
001527 (2016) |
Justin C. Brown [États-Unis] ; Andrea B. Troxel [États-Unis] ; Bonnie Ky [États-Unis] ; Nevena Damjanov [États-Unis] ; Babette S. Zemel [États-Unis] ; Michael R. Rickels [États-Unis] ; Andrew D. Rhim [États-Unis] ; Anil K. Rustgi [États-Unis] ; Kerry S. Courneya [Canada] ; Kathryn H. Schmitz [États-Unis] | A Randomized Phase II Dose-Response Exercise Trial among Colon Cancer Survivors: Purpose, Study Design, Methods, and Recruitment Results |
001529 (2016) |
Jeong Chan Ra ; Euicheol C. Jeong ; Sung Keun Kang ; Seog Ju Lee ; Kyoung Ho Choi | A Prospective, Nonrandomized, no Placebo-Controlled, Phase I/II Clinical Trial Assessing the Safety and Efficacy of Intramuscular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Patients With Severe Buerger’s Disease |
001684 (2015) |
K. Papp [Canada] ; D. Thaçi [Allemagne] ; K. Reich [Allemagne] ; E. Riedl [Autriche] ; R G Langley [Canada] ; J G Krueger [États-Unis] ; A B Gottlieb [États-Unis] ; H. Nakagawa [Japon] ; E P Bowman [États-Unis] ; A. Mehta [États-Unis] ; Q. Li [États-Unis] ; Y. Zhou [États-Unis] ; R. Shames [États-Unis] | Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial. |
001690 (2015) |
Baskaran Sundaram ; Jean W. Kuriakose ; Jadranka Stojanovska ; Kuanwong Watcharotone ; Robert A. Parker ; Ella A. Kazerooni | Thoracic Central Venous Evaluation: Comparison of First Pass Direct versus Delayed Phase Indirect Multidetector CT Venography |
001924 (2015) |
Wenze Sun [République populaire de Chine] ; Tao Wang [République populaire de Chine] ; Fan Shi [République populaire de Chine] ; Jiquan Wang [République populaire de Chine] ; Juan Wang [République populaire de Chine] ; Beina Hui [République populaire de Chine] ; Yingbing Zhang [République populaire de Chine] ; Jinli Lu [République populaire de Chine] ; Hongwei Chen [République populaire de Chine] ; Zi Liu [République populaire de Chine] | Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy |
001926 (2015) |
Martee L. Hensley ; Austin Miller ; David M. O'Malley ; Robert S. Mannel ; Kian Behbakht ; Jamie N. Bakkum-Gamez ; Helen Michael | Randomized Phase III Trial of Gemcitabine Plus Docetaxel Plus Bevacizumab or Placebo As First-Line Treatment for Metastatic Uterine Leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group Study |
001E51 (2015) |
Orçin Telli Atalay ; An L Özkir ; Bilge Ba Akçi Çalik ; Emre Baskan ; Harun Ta Kin | Effects of phase I complex decongestive physiotherapy on physical functions
and depression levels in breast cancer related lymph edema |
002247 (2015) |
Kathleen N. Moore [États-Unis] ; Michael W. Sill ; Meaghan E. Tenney ; Christopher J. Darus ; David Griffin ; Theresa L. Werner ; Peter G. Rose ; Robert Behrens | A Phase II Trial of Trebananib (AMG 386; IND#111071), a Selective Angiopoietin 1/2 Neutralizing Peptibody, in Patients with Persistent/Recurrent Carcinoma of the Endometrium: An NRG/Gynecologic Oncology Group Trial |
002366 (2014) |
Timothy M. Zagar ; Zeljko Vujaskovic ; Silvia Formenti ; Hope Rugo ; Franco Muggia ; Brigid O Onnor ; Robert Myerson ; Paul Stauffer ; I-Chow Hsu ; Chris Diederich ; William Straube ; Mary-Keara Boss ; Alina Boico ; Oana Craciunescu ; Paolo Maccarini ; David Needham ; Nicholas Borys ; Kimberly L. Blackwell [États-Unis] ; Mark W. Dewhirst | Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer |
002461 (2014) |
So Yeon Lee [Corée du Sud] ; Yong Joo Lee [Corée du Sud] ; Jung-Hwa Yang [Corée du Sud] ; Chul-Min Kim [Corée du Sud] ; Whan-Seok Choi [Corée du Sud] | The Association between Phase Angle of Bioelectrical Impedance Analysis and Survival Time in Advanced Cancer Patients: Preliminary Study |